Liquidia Technologies, Inc. (LQDA) Social Stream
Liquidia Corp (LQDA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LQDA.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 32 weeks, LQDA's average price target has gone up $6.
Over the past 49 weeks, LQDA's average upside potential has been 57.2%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
LQDA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
LQDA's average broker recommendation rating improved by 0.08 over the prior 28 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, Liquidia Corp's average analyst price target is greater than 41.53% of them.
- In terms of how Liquidia Corp fares relative to all US stocks, note that its number of analysts covering the stock is greater than 87.46% of that group.
- In terms of how Liquidia Corp fares relative to Medical Equipment stocks, note that its variance in analysts' estimates is lower than -319.58% of that group.
- To contextualize these metrics, consider that out of Healthcare stocks, Liquidia Corp's upside potential (average analyst target price relative to current price) is higher than 117.94% of them.
Is LQDA a Buy, Hold or Sell? See the POWR Ratings now!